Low bone mineral density and osteoporosis are well-known comorbidities with systemic lupus erythematosus. In this slideshow, we highlight six of the most common risk factors for low bone mineral density in SLE.
Bisphosphonates, bone health and more: In this slideshow, we revisit some of the studies presented at the American Society for Bone and Mineral Research annual meeting, which took place Sept. 16-19 in Atlanta.
Treating post-menopausal osteoporosis patients with romosozumab could improve their long-term bone density, a study shows.
Low protein intake may be responsible for fractures in older men, according to an observational study.
Using the fracture assessment tool with older, community-dwelling women can help reduce their risk of hip fracture over time, study shows.
Osteoporosis-related hip fractures are no longer on a downward trend in the U.S. A drop in reimbursement for a common screening technique could be to blame.
Using biomarkers to assess drug efficacy could pave the way for improved osteoporosis treatment, according to a new study.
Some patients are not being screened or treated for glucocorticoid-induced osteoporosis by primary care physicians or rheumatologists.
Should you prescribe Vitamin D to your patient to prevent fractures? If so, how much?
Osteoporosis is undertreated with only half of patients who qualify for a diagnosis receiving treatment. There are particular considerations for patients with rheumatologic illness.